HAVN Life Sciences
Vancouver
About HAVN Life Sciences
HAVN Life Sciences is a biotechnology company pursuing standardized extraction of psychedelic compounds for the creation of APIs, the development of natural health products, and innovative therapies to support central nervous system health and enhance the capabilities of the mind.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $17.6M
- Funding stage: IPO
- Last round: Post-IPO Debt (Jul 2022)
- Ticker: cnsx:HAVN
- Website: havnlife.com
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/havn-life-sciences-2238612 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.